Predicting outcomes in liver cancer with non-invasive tests
Part of Cancer, Digestive system clinical trials.
This study uses non-invasive tests, like scans or blood tests, to predict how well people with liver cancer (hepatocellular carcinoma, or HCC) will do after curative treatment. It may help doctors better understand your condition without needing invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a known chronic liver disease, such as cirrhosis or hepatitis
- You have been diagnosed with liver cancer (HCC) for the first time and are scheduled for treatment that aims to cure it, like surgery or a procedure to destroy the tumor
- You do not have advanced liver cirrhosis with complications like fluid in the belly or internal bleeding
- You have not had a liver transplant or are not planning to have one for this cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a 3D-printed model of your liver tumor to help doctors choose treatment that may prevent the cancer from coming back after surgery. The model predicts how your tumor might respond, so you get the most effective therapy.
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
This study is testing a special model that helps predict how well liver cancer might shrink with certain treatments. If you have advanced liver cancer that can still be treated, this model may help guide your care.
This study is looking at people with advanced liver cancer (HCC) that cannot be removed by surgery. Researchers want to see if certain markers in your blood or tumor can help predict how well you respond to a combination of chemotherapy delivered directly to the liver and immunotherapy. If you join, you will receive the planned treatment and provide additional blood and tissue samples for analysis.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study looks at new, non-invasive methods to predict when chronic liver disease might get worse. It could help you and your doctor catch problems early without needing a biopsy or other invasive procedures.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.